Rotavirus vaccine cuts infant diarrhoea deaths by a third in Malawi

August 11, 2018, University of Liverpool
Rotavirus vaccine cuts infant diarrhoea deaths by a third in Malawi
Malawian children. Credit: Dr Carina King

A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

The study led by scientists at the University of Liverpool, UCL, Johns Hopkins Bloomberg School of Public Health and partners in Malawi provides the first population-level evidence from a low-income country that rotavirus vaccination saves lives.

The findings, published in The Lancet Global Health, add considerable weight to the World Health Organisation's (WHO) recommendation for to be included in all national immunisation programmes.

Professor Nigel Cunliffe from the University of Liverpool's Centre for Global Vaccine Research, one of the study leads, said: "Rotavirus remains a leading cause of severe diarrhoea and death among infants and young children in many countries in Africa and Asia. Our findings strongly advocate for the incorporation of rotavirus vaccine into the childhood immunisation programmes of countries with high rates of diarrhoea deaths, and support continued use in such countries where a vaccine has been introduced."

Rotavirus is the most common cause of diarrhoeal disease among infants and young children. Despite improvements in sanitation and case management, rotavirus still caused 215,000 child deaths in 2013, with 121,000 of these in Africa. With support from Gavi, the Vaccine Alliance, many countries in Africa with high death rates have added rotavirus vaccine to their routine immunisation programme over the past five years.

To determine the vaccine's impact on infant diarrhoea deaths, researchers carried out a large population-based birth cohort study of 48,672 infants in Malawi, which introduced a monovalent rotavirus vaccine in October 2012.

As low-income African countries often lack birth and registries—a resource used for similar impact studies in middle-income countries—the investigators and their study team of more than 1,100 people visited the homes of infants in 1,832 villages over the course of four years to collect data, including the infants' vaccination status and whether they survived to age one.

The study findings reveal that children who received the rotavirus vaccine had a 34% lower risk of dying from diarrhoea, which is a similar impact to that observed in middle-income countries.

"This is encouraging because children from the sub-Saharan African region account for more than half of global , and with over 30 African countries thus far introducing rotavirus vaccine, the absolute impact on mortality is likely to be substantial," said one of the report's lead authors Dr. Carina King, a senior research associate at UCL's Institute for Global Health.

Co-lead author Dr. Naor Bar-Zeev, Associate Professor of International Health at the International Vaccine Access Center of the Johns Hopkins Bloomberg School of Public Health, added: "We already knew that rotavirus vaccine reduces hospital admissions and is highly cost-effective in low-income countries with a high burden of diarrhoeal disease, and now we've been able to demonstrate that it saves lives.

"However not all countries are vaccinating against rotavirus yet, including some very populous countries. The key message of this paper is that to do the best by all our children and to help them survive, all countries should introduce rotavirus vaccination."

The researchers also found a direct link between the proportion of the population vaccinated and the reduction in mortality that achieved. Malawi had a strong immunisation programme and was very proactive in planning to introduce rotavirus vaccine, which made it possible to scale up coverage rapidly.

"Within about a year from introduction, we were able to reach up to 90% of the population. It is vitally important that rotavirus vaccines reach all children, especially the most vulnerable living in poorer settings where the impact of vaccination is greatest," said one of the authors Dr. Charles Mwansambo, Chief of Health Services for Malawi.

Explore further: Rotavirus vaccine reduces severe diarrhoea by 64 percent in Malawi

Related Stories

Rotavirus vaccine reduces severe diarrhoea by 64 percent in Malawi

January 29, 2015
Research at the University of Liverpool has found that diarrhoea caused by rotavirus infection is significantly reduced in the developing world with the use of a vaccine to prevent the condition.

Rotavirus vaccine could reduce UK health inequalities, new study suggests

January 29, 2018
New research led by the University of Liverpool has found that childhood vaccination against rotavirus has greatest benefit in the most deprived communities and could contribute to reducing health inequalities in the UK.

Researchers successfully develop a rotavirus vaccine which could benefit millions of children

February 22, 2018
Researchers from the Murdoch Children's Research Institute (MCRI) have developed a rotavirus vaccine that provides earlier protection from dehydrating diarrhoea for infants and young children.

Waging war against rotavirus

April 10, 2012
Canada should show leadership in supporting adoption of the rotavirus vaccination in developing countries, but it must also ensure that all Canadian infants are vaccinated against the virus, states an editorial in CMAJ (Canadian ...

New low-cost rotavirus vaccine could reduce disease burden in developing countries

March 22, 2017
A new vaccine for rotavirus was found to be 66.7% effective in preventing severe gastroenteritis caused by the virus, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Epicentre, Paris. ...

Lives could be saved by removing age restrictions on rotavirus vaccination

October 23, 2012
A study published in this week's PLOS Medicine, which suggests that the additional children's lives saved by removing the age restrictions for rotavirus vaccination in low- and middle-income countries would be much greater ...

Recommended for you

A versatile vaccine that can protect mice from emerging tick-borne viruses

December 18, 2018
A group of researchers led by Michael Diamond of Washington University School of Medicine in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause ...

How cholera bacteria make people so sick

December 18, 2018
The enormous adaptability of the cholera bacterium explains why it is able to claim so many victims. Professor Ariane Briegel from the Leiden Institute of Biology has now discovered that this adaptability is due to rapid ...

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.